Turkish Version of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire: A Reliability and Validity Study

Overview

Journal Arch Rheumatol

Specialty Rheumatology

Date 2024 Jun 27

PMID 38933717

Authors

Mehmet Alptekin Karacesme

Manolya Ilhanli

Ilker Ilhanli

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aimed to analyze the validity and reliability of the Turkish version of the Massachusetts General Hospital Cognitive and Physical Functioning Questionnaire (CPFQ) in patients with fibromyalgia (FM) syndrome by translating and culturally adapting the CPFQ to Turkish.

Patients And Methods: One hundred seventeen patients (8 males, 109 females; mean age: 47.4±12.4 years; range, 18 to 77 years) diagnosed with FM according to the 2016 American College of Rheumatology FM diagnostic criteria between May 2021 and August 2021 were included in the reliability and validity study. The CPFQ was translated into Turkish, the intelligibility of the obtained Turkish version was evaluated by five patients and five healthcare professionals, and the final form of the questionnaire was prepared. Mini-mental state examination (MMSE), Fibromyalgia Impact Questionnaire (FIQ), and Hospital Anxiety and Depression Scale (HADS), which were proven to be reliable and valid in Turkish, were administered to the patients. For test-retest reliability, the Turkish version of the CPFQ was filled in two times with an interval of one week. Internal consistency was evaluated by calculating Cronbach's alpha. Validity was evaluated by looking at the correlations between the total score obtained from the Turkish version of CPFQ and the MMSE score, HADS depression and anxiety scores, and FIQ score.

Results: In the evaluation of internal consistency, Cronbach's alpha was found to be high in all subgroups. In test-retest reliability, intraclass correlation coefficient was high in CPFQ subgroups. The CPFQ showed a significant positive correlation with HADS depression and a moderately positive correlation with HADS anxiety and FIQ. A significant but weak negative correlation was detected between CPFQ and MMSE. While there was no significant correlation between MMSE and FM disease activity and HADS anxiety, there was a significant but weak negative correlation between HADS depression.

Conclusion: In this study, the Turkish version of CPFQ was shown to have high reliability and validity in FM patients. It was concluded that CPFQ could be applied to Turkish patients with FM.

References

Harker K, Klein R, Dick B, Verrier M, Rashiq S . Exploring attentional disruption in fibromyalgia using the attentional blink. Psychol Health. 2011; 26(7):915-29. DOI: 10.1080/08870446.2010.525639. View

Can S, Gencay-Can A, Gunendi Z . Validity and reliability of the clock drawing test as a screening tool for cognitive impairment in patients with fibromyalgia. Compr Psychiatry. 2011; 53(1):81-6. DOI: 10.1016/j.comppsych.2011.02.001. View

Bar-On Kalfon T, Gal G, Shorer R, Ablin J . Cognitive functioning in fibromyalgia: The central role of effort. J Psychosom Res. 2016; 87:30-6. DOI: 10.1016/j.jpsychores.2016.06.004. View

Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia D . Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012; 2012:426130. PMC: 3503476. DOI: 10.1155/2012/426130. View

Glass J . Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control impairments. Rheum Dis Clin North Am. 2009; 35(2):299-311. DOI: 10.1016/j.rdc.2009.06.002. View

Pericot-Nierga I, Hernandez-Ferrandiz M, Lozano-Gallego M, Vilalta-Franch J, Cruz-Reina M, Lopez-Pousa S . [Cognitive profile in fibromyalgia. Comparison with a mild cognitive impairment group]. Med Clin (Barc). 2009; 133(3):91-4. DOI: 10.1016/j.medcli.2008.10.051. View

Bradley L . Pathophysiology of fibromyalgia. Am J Med. 2009; 122(12 Suppl):S22-30. PMC: 2821819. DOI: 10.1016/j.amjmed.2009.09.008. View

Rodriguez-Andreu J, Ibanez-Bosch R, Portero-Vazquez A, Masramon X, Rejas J, Galvez R . Cognitive impairment in patients with fibromyalgia syndrome as assessed by the mini-mental state examination. BMC Musculoskelet Disord. 2009; 10:162. PMC: 2811106. DOI: 10.1186/1471-2474-10-162. View

10.

Yilmaz E, Tamam L . Attention-deficit hyperactivity disorder and impulsivity in female patients with fibromyalgia. Neuropsychiatr Dis Treat. 2018; 14:1883-1889. PMC: 6063452. DOI: 10.2147/NDT.S159312. View

11.

Grace G, Nielson W, Hopkins M, Berg M . Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol. 1999; 21(4):477-87. DOI: 10.1076/jcen.21.4.477.876. View

12.

Folstein M, Folstein S, McHugh P . "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12(3):189-98. DOI: 10.1016/0022-3956(75)90026-6. View

13.

Yunus M, MASI A, Calabro J, Miller K, Feigenbaum S . Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum. 1981; 11(1):151-71. DOI: 10.1016/0049-0172(81)90096-2. View

14.

Queiroz L . Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep. 2013; 17(8):356. DOI: 10.1007/s11916-013-0356-5. View

15.

Sarmer S, Ergin S, Yavuzer G . The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2001; 20(1):9-12. DOI: 10.1007/s002960000077. View

16.

Bennett R . Clinical manifestations and diagnosis of fibromyalgia. Rheum Dis Clin North Am. 2009; 35(2):215-32. DOI: 10.1016/j.rdc.2009.05.009. View

17.

Park D, Glass J, Minear M, Crofford L . Cognitive function in fibromyalgia patients. Arthritis Rheum. 2001; 44(9):2125-33. DOI: 10.1002/1529-0131(200109)44:9<2125::AID-ART365>3.0.CO;2-1. View

18.

Martinez-Lavin M, Lopez S, Medina M, Nava A . Use of the leeds assessment of neuropathic symptoms and signs questionnaire in patients with fibromyalgia. Semin Arthritis Rheum. 2003; 32(6):407-11. DOI: 10.1053/sarh.2003.50017. View

19.

Shaked D, Faulkner L, Tolle K, Wendell C, Waldstein S, Spencer R . Reliability and validity of the Conners' Continuous Performance Test. Appl Neuropsychol Adult. 2019; 27(5):478-487. DOI: 10.1080/23279095.2019.1570199. View

20.

Clauw D . Fibromyalgia: a clinical review. JAMA. 2014; 311(15):1547-55. DOI: 10.1001/jama.2014.3266. View